In-Silico Validation and Development of Chlorogenic Acid (CGA) Loaded Polymeric Nanoparticle for Targeting Neurodegenerative Disorders
Open Access
- 1 January 2020
- journal article
- research article
- Published by Scientific Research Publishing, Inc. in Journal of Biomaterials and Nanobiotechnology
- Vol. 11 (04), 279-303
- https://doi.org/10.4236/jbnb.2020.114018
Abstract
Background: Recent decades witnessed a significant growth in terms of phytocompounds based therapeutics, extensively explored for almost all types of existing disorders. They have also been widely investigated in Neurodegenerative disorders (NDDs) and Chlorogenic acid (CGA), a polyphenolic compound having potential anti-inflammatory and anti-oxidative properties, emerged as a promising compound in ameliorating NDDs. Owing to its poor stability, bioavailability and release kinetics, CGA needed a suitable nanocarrier based pharmaceutical design for targeting NDDs. Objective: The current study is aimed at the in-silico validation of CGA as an effective therapeutic agent targeting various NDDs followed by the fabrication of polymeric nanoparticles-based carrier system to overcome its pharmacological limitations and improve its stability. Methods: A successful in-silico validation using molecular docking techniques along with synthesis of CGA loaded polymeric nanoparticles (CGA-NPs) by ionic gelation method was performed. The statistical optimisation of the developed CGA-NPs was done by Box Behnken method and then the optimized formulation of CGA-NPs was characterised using particle size analysis (PSA), Transmission electron microscopy (TEM), Fourier Transform Infrared spectroscopy (FTIR) along with in-vitro release kinetics analysis. Results & Conclusion: The results attained exhibited average particle size of 101.9 ± 1.5 nm, Polydispersibility (PDI) score of 0.065 and a ZP of −17.4 mV. On a similar note, TEM results showed a size range of CGA-NPs between 90 - 110 nm with a spherical shape of NPs. Also, the data from in-vitro release kinetics showed a sustained release of CGA from the NPs following the first-order kinetics suggesting the appropriate designing of nanoformulation.Keywords
This publication has 71 references indexed in Scilit:
- Effects of Particle Size and Surface Modification on Cellular Uptake and Biodistribution of Polymeric Nanoparticles for Drug DeliveryPharmaceutical Research, 2013
- In VitroRelease Kinetics of Antituberculosis Drugs from Nanoparticles Assessed Using a Modified Dissolution ApparatusBioMed Research International, 2013
- Quantitative analysis of phenolic components and glycoalkaloids from 20 potato clones and in vitro evaluation of antioxidant, cholesterol uptake, and neuroprotective activitiesFood Chemistry, 2012
- Polymeric nanoparticles for drug delivery to the central nervous systemAdvanced Drug Delivery Reviews, 2012
- Preparation, Statistical Optimization, and In vitro Characterization of Insulin Nanoparticles Composed of Quaternized Aromatic Derivatives of ChitosanAAPS PharmSciTech, 2011
- Controlled Growth of Nanoparticles from Solution with In Situ Liquid Transmission Electron MicroscopyNano Letters, 2011
- Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken designInternational Journal of Nanomedicine, 2011
- The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studiesJournal of Biomedical Science, 2011
- Cholinesterase inhibitory activities of some flavonoid derivatives and chosen xanthone and their molecular docking studiesChemico-Biological Interactions, 2009
- FTIR investigation of the interaction of tumor cells treated with caffeic acid and chlorogenic acidVibrational Spectroscopy, 2000